Database

Startups

Main Industry
Health Care
Main Product/Service
VITAE Biomedical offers a Urine‑based Lung Cancer ELISA Reagent Kit, which uses dual highly specific antibodies in a sandwich assay to detect lung cancer–associated proteins in urine. The test shows high sensitivity and specificity, is CE‑certified in the
Founded Year
2017
Unified Business No.
55623255
Status
Active
Number of Employees
0
Total Paid-in Capital
73,002,000 (NT$)
Location of Company
Taiwan , Taipei City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.
About the Company
VITAE Biomedical Co., Ltd., founded in 2019, is a molecular diagnostics biotech company focused on developing fast, accurate, and cost-effective automated cancer screening technologies. Their R&D team, primarily from Academia Sinica, aims to bring real-wo



More ↓

Similar Companies